Novel therapeutics for dry eye disease.
作者信息
Wu Duoduo, Tong Louis, Prasath Arun, Lim Blanche Xiao Hong, Lim Dawn Ka-Ann, Lim Chris Hong Long
机构信息
Department of Ophthalmology, National University Health System, Singapore, Singapore.
Singapore Eye Research Institute, Singapore, Singapore.
出版信息
Ann Med. 2023 Dec;55(1):1211-1212. doi: 10.1080/07853890.2023.2189749.
Abstract
摘要
相似文献
1
Novel therapeutics for dry eye disease.干眼症的新型疗法。
Ann Med. 2023 Dec;55(1):1211-1212. doi: 10.1080/07853890.2023.2189749.
2
[Conservative treatment of dry eye].[干眼症的保守治疗]
Klin Monbl Augenheilkd. 2014 Nov;231(11):1093-6. doi: 10.1055/s-0034-1382976. Epub 2014 Oct 2.
3
Diquafosol tetrasodium: a novel dry eye therapy.四水合二喹法索钠：一种新型干眼症治疗药物。
Expert Opin Investig Drugs. 2004 Jan;13(1):47-54. doi: 10.1517/13543784.13.1.47.
4
Recent Patents and Emerging Therapeutics on Ocular Inflammation and Allergy.眼部炎症与过敏方面的近期专利及新兴疗法
Recent Pat Inflamm Allergy Drug Discov. 2017;11(2):92-106. doi: 10.2174/1872213X11666170913150146.
5
Lifitegrast Ophthalmic Solution 5%: A Review in Dry Eye Disease.利福平滴眼剂 5%：用于干燥性眼病的综述。
Drugs. 2017 Feb;77(2):201-208. doi: 10.1007/s40265-016-0681-1.
6
Outcome Measures to Assess Dry Eye Severity: A Review.评估干眼严重程度的结局指标：综述
Ocul Immunol Inflamm. 2022 Feb 17;30(2):282-289. doi: 10.1080/09273948.2022.2027461. Epub 2022 Feb 3.
7
Varenicline nasal spray (Tyrvaya) for dry eye disease.用于治疗干眼症的伐尼克兰鼻喷雾剂（Tyrvaya）。
Med Lett Drugs Ther. 2021 Dec 13;63(1639):198-199.
8
Rationale for anti-inflammatory therapy in dry eye syndrome.干眼症抗炎治疗的理论依据。
Arq Bras Oftalmol. 2008 Nov-Dec;71(6 Suppl):89-95. doi: 10.1590/s0004-27492008000700017.
9
Ciclosporin use in dry eye disease patients.环孢素在干眼症患者中的应用。
Expert Opin Pharmacother. 2008 Dec;9(17):3121-8. doi: 10.1517/14656560802500613.
10
[Choice of eye drops for the therapy of dry eye].
Nippon Ganka Gakkai Zasshi. 2012 Dec;116(12):1121-2.
引用本文的文献
1
Applications of Diquafosol Sodium in Ophthalmology: A Comprehensive Review of Therapeutic Utility.地夸磷索钠在眼科的应用：治疗效用的全面综述
Life (Basel). 2025 Mar 17;15(3):484. doi: 10.3390/life15030484.
本文引用的文献
1
Dry eye disease: identification and therapeutic strategies for primary care clinicians and clinical specialists.干眼症：初级保健临床医生和临床专家的识别和治疗策略。
Ann Med. 2023 Dec;55(1):241-252. doi: 10.1080/07853890.2022.2157477.
2
Comparison of epitheliotrophic factors in platelet-rich plasma versus autologous serum and their treatment efficacy in dry eye disease.富血小板血浆与自体血清中促上皮生长因子的比较及其在干眼症中的治疗效果。
Sci Rep. 2022 May 26;12(1):8906. doi: 10.1038/s41598-022-12879-x.
3
Comparison of the efficacy between topical diquafosol and artificial tears in the treatment of dry eye following cataract surgery: A meta-analysis of randomized controlled trials.局部用双醋瑞因与人工泪液治疗白内障术后干眼疗效的比较：一项随机对照试验的荟萃分析
Medicine (Baltimore). 2017 Sep;96(39):e8174. doi: 10.1097/MD.0000000000008174.
4
Plasma-mediated immune suppression: a neonatal perspective.血浆介导的免疫抑制：新生儿视角。
Pediatr Allergy Immunol. 2013 Mar;24(2):102-13. doi: 10.1111/pai.12023. Epub 2012 Nov 22.
5
Diquafosol ophthalmic solution for dry eye treatment.地夸磷索钠滴眼液治疗干眼症。
Adv Ther. 2012 Jul;29(7):579-89. doi: 10.1007/s12325-012-0033-9. Epub 2012 Jul 27.
Zotero 插件